Aktienkurs
3.64
Täglich Wechseln
0.28 8.33%
Monatlich
-29.73%
Jährlich
112.87%
Q1 Prognose
3.84




SCHULD Veränderung Datum
Acadia Pharmaceuticals USD 54.81M 1.48M 2025-09
Agios Pharmaceuticals USD 44.52M 4.24M 2025-09
Akebia Therapeutics USD 46.51M 7.82M 2025-03
Alnylam Pharmaceuticals USD 1.31B 11.39M 2025-09
Amarin USD 0 0 2025-03
Ardelyx USD 207.61M 968K 2025-09
Astellas Pharma JPY 831.43B 83.94B 2025-03
AstraZeneca USD 32.63B 207M 2025-09
Charles River Laboratories USD 2.63B 157.4M 2025-09
Coherus Biosciences USD 294.92M 1.25M 2025-03
Emergent BioSolutions USD 903.2M 495.2M 2023-06
Esperion Therapeutics USD 262.92M 1.76M 2024-09
Exact Sciences USD 2.34B 15.24M 2025-09
Halozyme Therapeutics USD 1.51B 1.66M 2025-09
Incyte USD 40.41M 855K 2025-12
Ironwood Pharmaceuticals USD 583.99M 14.83M 2024-12
Karyopharm Therapeutics USD 264.09M 39.31M 2024-09
Lexicon Pharmaceuticals USD 99.26M 493K 2023-09
MacroGenics USD 37.01M 238K 2025-09
Moderna USD 734M 7M 2025-09
Myriad Genetics USD 59.3M 19.7M 2025-03
Pacira USD 376.72M 203.77M 2025-09
PTC Therapeutics USD 286.32M 306K 2025-09
Puma Biotechnology USD 89.06M 55.07M 2024-06
Sarepta Therapeutics USD 1.25B 103.69M 2025-09
Takeda JPY 4.85T 208B 2025-12
Ultragenyx Pharmaceutical USD 33.83M 2.46M 2025-09
Vanda Pharmaceuticals USD 4.96M 4.96M 2024-12


Ironwood Pharmaceuticals SCHULD - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Feb 2026.